Blindness resulting from bisphosphonate-related osteonecrosis of the skull base
Acta Oto-Laryngologica Case Reports · 2016
DOI: 10.1080/23772484.2016.1209641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Oto-Laryngologica Case Reports, 2016. Verfasst von Farhoud Faraji und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a rare, serious complication of bisphosphonate therapy. We report here a 69-year-old man with a history of multiple myeloma and 5 years of adjuvant zoledronate therapy presenting with loss of light perception, proptosis, ptosis and impaired abduction of the right eye. This patient was found to have developed an unusually severe presentation of osteomyelitis of the skull base in the setting of BRONJ that ultimately led to unilateral blindness. In this extreme case of bisphosphonate-related osteonecrosis of the skull base, we reveal the importance of early identification and treatment of these lesions. This is the first description of BRONJ-induced blindness.
Zitieren
APA
Faraji, F., Antisdel, J. L., & Brunworth, J. D. (2016). Blindness resulting from bisphosphonate-related osteonecrosis of the skull base. Acta Oto-Laryngologica Case Reports. https://doi.org/10.1080/23772484.2016.1209641
Vancouver
Faraji F, Antisdel JL, Brunworth JD. Blindness resulting from bisphosphonate-related osteonecrosis of the skull base. Acta Oto-Laryngologica Case Reports. 2016. doi:10.1080/23772484.2016.1209641
BibTeX
@article{Faraji2016,
author = {Faraji, Farhoud and Antisdel, Jastin L. and Brunworth, Joseph D.},
title = {Blindness resulting from bisphosphonate-related osteonecrosis of the skull base},
journal = {Acta Oto-Laryngologica Case Reports},
year = {2016},
doi = {10.1080/23772484.2016.1209641}
}
EUVIMED